Delivery Order SPE2DB20D3505-SPE2DB23FU4X3

Award Date 7/31/23
Potential Completion Date 8/1/23
Potential Value $164
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $246.66 delivery order to Amerisourcebergen Drug Corporation for RHOPRESSA 0.02% ophthalmic solution. The firm fixed price order is to supply 2.5mL of the solution and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania between August 16-17, 2023. As a major distributor of pharmaceuticals and medical supplies for the Department of Defense, Amerisourcebergen routinely supports the DLA's mission to provide critical logistics...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $1,075 to Amerisourcebergen Drug Corporation for RHOPRESSA 0.02% ophthalmic solution. The order is to be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day, from August 10th through the 11th of 2023. Amerisourcebergen Drug Corporation is a division of Amerisourcebergen Corporation, which will perform as the prime contractor. No...
The Defense Logistics Agency Troop Support Medical awarded a $493 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RHOPRESSA 0.02% ophthalmic solution. The order is to be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility by September 7, 2023. Amerisourcebergen Drug Corporation is a division of Amerisourcebergen Corporation, which will perform as the prime contractor. No subcontractors or set aside designations were indicated. The Defense Logistics...
The Defense Logistics Agency awarded a $848.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RHOPRESSA 0.02% ophthalmic solution. The contract has a period of performance from September 1-5, 2023, with all work to be conducted by Amerisourcebergen at its facility in Conshohocken, Pennsylvania. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation. No subcontractors or set aside designations were identified. The Defense Logistics...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $986 to Amerisourcebergen Drug Corporation for RHOPRESSA 0.02% ophthalmic solution. The contract has a period of performance from July 25, 2023 through July 26, 2023. Place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. No major subcontractors or set aside designations were indicated. This delivery order was issued against an existing...
The Defense Logistics Agency awarded a $164 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RHOPRESSA 0.02% ophthalmic solution. As the prime contractor, Amerisourcebergen will supply the eye medication to support DLA needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in early August 2023. No subcontractors or set aside designations were identified. This order is consistent with DLA's role to procure...
The Defense Logistics Agency awarded a $275.94 delivery order to Amerisourcebergen Drug Corporation for RHOPRESSA 0.02% ophthalmic solution. As the prime contractor, Amerisourcebergen will deliver the specified pharmaceutical product to a Conshohocken, Pennsylvania facility under a firm fixed price contract concluding on September 6, 2023. The order was placed under an existing DLA-managed indefinite delivery vehicle and supports the Agency's medical supply chain responsibilities for the...
The Defense Logistics Agency awarded a $995 delivery order to Amerisourcebergen Drug Corporation for RHOPRESSA 0.02% ophthalmic solution. The firm fixed price order is valued at approximately one thousand dollars to supply the 2.5mL ophthalmic solution. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a two day period in early September 2023. No set aside designation or subcontractors were identified. The Defense Logistics Agency routinely contracts for...
The Defense Logistics Agency awarded a $328.88 delivery order to Amerisourcebergen Drug Corporation for RHOPRESSA 0.02% ophthalmic solution. As the prime contractor, Amerisourcebergen will supply 2.5mL bottles of the glaucoma medication to support DLA programs. The firm fixed price order is for performance from August 8-9, 2023 at Amerisourcebergen's facility in Conshohocken, Pennsylvania. No subcontractors or set aside designations were identified. This award draws from DLA's pharmaceutical...
The Defense Logistics Agency awarded a $441,940 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RHOPRESSA 0.02% ophthalmic solution. The order is being fulfilled under the prime contractor's corporate office division from its facility in Conshohocken, Pennsylvania. The solution will support DLA's medical supply needs from August 3rd to August 4th, 2023. No set aside designation or subcontractors were indicated. DLA manages the global supply chain for the United States...
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB23FU4X3
    Delivery Order

The Defense Logistics Agency awarded a $164,440 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RHOPRESSA 0.02% ophthalmic solution. The order is being fulfilled under the prime contractor's Corporate Office Division operations in Conshohocken, Pennsylvania, with performance spanning from July 31 to August 1, 2023. As a leading supplier of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen will deliver the requested ophthalmic products to directly support DLA's vision care programs. No subcontractors or set aside designations were indicated in the award information provided.

Generated 12/17/23, 7:13 AM